BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11158329)

  • 1. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators.
    De Bosscher K; Vanden Berghe W; Haegeman G
    Mol Endocrinol; 2001 Feb; 15(2):219-27. PubMed ID: 11158329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
    McKay LI; Cidlowski JA
    Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
    Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
    Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
    Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
    Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway.
    Caelles C; González-Sancho JM; Muñoz A
    Genes Dev; 1997 Dec; 11(24):3351-64. PubMed ID: 9407028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell.
    De Bosscher K; Vanden Berghe W; Vermeulen L; Plaisance S; Boone E; Haegeman G
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3919-24. PubMed ID: 10760263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.
    De Bosscher K; Beck IM; Dejager L; Bougarne N; Gaigneaux A; Chateauvieux S; Ratman D; Bracke M; Tavernier J; Vanden Berghe W; Libert C; Diederich M; Haegeman G
    Cell Mol Life Sci; 2014 Jan; 71(1):143-63. PubMed ID: 23784308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.
    Delerive P; De Bosscher K; Besnard S; Vanden Berghe W; Peters JM; Gonzalez FJ; Fruchart JC; Tedgui A; Haegeman G; Staels B
    J Biol Chem; 1999 Nov; 274(45):32048-54. PubMed ID: 10542237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
    Chatterjee VK; Madison LD; Mayo S; Jameson JL
    Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/activator protein-1 elements.
    Smith PJ; Cousins DJ; Jee YK; Staynov DZ; Lee TH; Lavender P
    J Immunol; 2001 Sep; 167(5):2502-10. PubMed ID: 11509589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids antagonize AP-1 by inhibiting the Activation/phosphorylation of JNK without affecting its subcellular distribution.
    González MV; Jiménez B; Berciano MT; González-Sancho JM; Caelles C; Lafarga M; Muñoz A
    J Cell Biol; 2000 Sep; 150(5):1199-208. PubMed ID: 10974006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
    Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1.
    Sheppard KA; Phelps KM; Williams AJ; Thanos D; Glass CK; Rosenfeld MG; Gerritsen ME; Collins T
    J Biol Chem; 1998 Nov; 273(45):29291-4. PubMed ID: 9792627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.
    Vanden Berghe W; Francesconi E; De Bosscher K; Resche-Rigon M; Haegeman G
    Mol Pharmacol; 1999 Oct; 56(4):797-806. PubMed ID: 10496964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARalpha and GR differentially down-regulate the expression of nuclear factor-kappaB-responsive genes in vascular endothelial cells.
    Xu X; Otsuki M; Saito H; Sumitani S; Yamamoto H; Asanuma N; Kouhara H; Kasayama S
    Endocrinology; 2001 Aug; 142(8):3332-9. PubMed ID: 11459775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors.
    Eberhardt W; Schulze M; Engels C; Klasmeier E; Pfeilschifter J
    Mol Endocrinol; 2002 Aug; 16(8):1752-66. PubMed ID: 12145332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation.
    De Bosscher K; Schmitz ML; Vanden Berghe W; Plaisance S; Fiers W; Haegeman G
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13504-9. PubMed ID: 9391055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness.
    Bantel H; Schmitz ML; Raible A; Gregor M; Schulze-Osthoff K
    FASEB J; 2002 Nov; 16(13):1832-4. PubMed ID: 12223450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.